These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 533879)

  • 1. Synthesis, redox characteristics, and in vitro norepinephrine uptake inhibiting properties of 2-(2-mercapto-4,5-dihydroxyphenyl)ethylamine (6-mercaptodopamine).
    Chavdarian CG; Castagnoli N
    J Med Chem; 1979 Nov; 22(11):1317-22. PubMed ID: 533879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and physicochemical and neurotoxicity studies of 1-(4-substituted-2,5-dihydroxyphenyl)-2-aminoethane analogues of 6-hydroxydopamine.
    Cheng AC; Castagnoli N
    J Med Chem; 1984 Apr; 27(4):513-20. PubMed ID: 6423824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and biological studies of 1-(2,5-dihydroxy-4-methylphenyl)-2-aminopropane, an analogue of 6-hydroxydopamine.
    Jacob P; Kline T; Castagnoli N
    J Med Chem; 1979 Jun; 22(6):662-71. PubMed ID: 458821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanisms of 6-hydroxydopamine cytotoxicity.
    Jonsson G
    Med Biol; 1976 Dec; 54(6):406-20. PubMed ID: 1034180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 2-and/or 5-methylated analogues of 6-hydroxydopamine on norepinephrine-and dopamine-containing neurons.
    Liang YO; Adams RN
    Mol Pharmacol; 1977 Sep; 13(5):805-18. PubMed ID: 895717
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 6-hydroxydopamine on daily variations of 5-HT synthesis in the hypothalamus of the rat.
    Héry F; Rouer E; Clowinski J
    Brain Res; 1973 Aug; 58(1):135-46. PubMed ID: 4731196
    [No Abstract]   [Full Text] [Related]  

  • 7. The biochemical and pharmacological properties of 6-aminodopamine: similarity with 6-hydroxydopamine.
    Heikkila RE; Mytilineou C; Côté LJ; Cohen G
    J Neurochem; 1973 Jul; 21(1):111-6. PubMed ID: 4720889
    [No Abstract]   [Full Text] [Related]  

  • 8. Isomers of 2,4,5-trihydroxyphenethylamine (6-hydroxydopamine): long-term effects on the accumulation of (3H)-norepinephrine in mouse heart in vivo.
    Lundstrom J; Ong H; Daly J; Creveling CR
    Mol Pharmacol; 1973 Jul; 9(4):505-13. PubMed ID: 4725781
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 6-hydroxydopamine on pineal norepinephrine content and enzyme activity in the cyclic female rat.
    Shivers BD; Fix JA; Yochim JM
    Biol Reprod; 1979 Sep; 21(2):393-9. PubMed ID: 573639
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective depletion of dopamine following O-methylation of 6-hydroxydopamine.
    Ho BT; Meyer AL; Taylor D
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):47-56. PubMed ID: 4734016
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of catecholamine uptake by 6-hydroxydopamine in rat brain.
    Iversen LL
    Eur J Pharmacol; 1970; 10(3):408-10. PubMed ID: 5422468
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of pretreatment with 6-hydroxydopamine on the uptake and metabolism of catecholamines by the isolated perfused rat heart.
    Hellmann G; Hertting G; Peskar B
    Br J Pharmacol; 1971 Feb; 41(2):270-7. PubMed ID: 5572277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 6-hydroxydopamine on hypothalamic norepinephrine and dopamine content, ultrastructure of the median eminence, and plasma corticosterone.
    Cuello AC; Shoemaker WJ; Ganong WF
    Brain Res; 1974 Sep; 78(1):57-69. PubMed ID: 4376442
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of intrahypothalamic injection of 6-hydroxydopamine on predatory aggression in rat.
    Jimerson D; Reis DJ
    Brain Res; 1973 Oct; 61():141-52. PubMed ID: 4797930
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenaline, noradrenaline and dopamine levels in brain and heart after administration of 6-hydroxydopamine and guanethedine to newborn mice.
    Liuzzi A; Foppen FH; Angeletti PU
    Biochem Pharmacol; 1974 Mar; 23(6):1041-4. PubMed ID: 4824904
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of the blood-brain barrier for 6-hydroxydopamine.
    Sachs C
    J Neurochem; 1973 Jun; 20(6):1753-60. PubMed ID: 4719317
    [No Abstract]   [Full Text] [Related]  

  • 17. Intracyclization rates of 6-hydroxydopamine and 6-aminodopamine analogs under physiological conditions.
    Blank CL; McCreery RL; Wightman RM; Chey W; Adams RN; Reid JR; Smissman EE
    J Med Chem; 1976 Jan; 19(1):178-80. PubMed ID: 1246041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 19. Excretion of norepinephrine and dopamine alcoholic metabolites after 6-hydroxydopamine.
    Karoum F; Costa E
    Biochem Pharmacol; 1974 Feb; 23(3):533-8. PubMed ID: 4822740
    [No Abstract]   [Full Text] [Related]  

  • 20. Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine.
    Lidbrink P; Jonsson G
    J Neurochem; 1974 May; 22(5):617-26. PubMed ID: 4152079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.